Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection
Clinical trial NCT04363814 · UNKNOWN
Trial details
- NCT number
- NCT04363814
- Sponsor
- Inmunotek S.L.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-10
- Primary completion
- 2022-01-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.